Evidence map›Paper›PMID 37587081›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2023

Endometrioid adenocarcinoma of the rectovaginal septum: A case report.

Qingling Mu, Chun Wang, Hongyun Liu, Youzheng Xu, Shaohong Luan, Baoguo Xia

Abstract readCase Reports
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qingling MuDepartment of Gynecology, Qingdao Municipal Hospital (Group), Qingdao Shandong 266000. muqingling1@163.com.
Chun WangDepartment of Gynecology, Qingdao Municipal Hospital (Group), Qingdao Shandong 266000.
Hongyun LiuDepartment of Pathology, Qingdao Municipal Hospital (Group), Qingdao Shandong 266000, China.
Youzheng XuDepartment of Gynecology, Qingdao Municipal Hospital (Group), Qingdao Shandong 266000.
Shaohong LuanDepartment of Gynecology, Qingdao Municipal Hospital (Group), Qingdao Shandong 266000.
Baoguo XiaDepartment of Gynecology, Qingdao Municipal Hospital (Group), Qingdao Shandong 266000. qdsslyyfk@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary endometrioid adenocarcinoma of the rectovaginal septum is rare. Its pathogenesis is not clear and there is no standard treatment. One patient with endometrioid adenocarcinoma of the rectovaginal septum arising from deep infiltrative endometriosis was admitted to Qingdao Municipal Hospital. The patient presented with incessant menstruation and abdominal distension. She had bilateral ovarian endometriotic cystectomy 6 years ago. Imaging findings suggested a pelvic mass which might invade the rectovaginal septum. Pathological results of primary surgery confirmed endometrioid carcinoma of the pelvic mass arising from the rectovaginal septum. Then she had a comprehensive staged surgery. Postoperative chemotherapy was given 6 times. No recurrence or metastasis was found during the 2-year follow-up. The possibility of deep infiltrating endometriosis and its malignant transformation should be considered in the differential diagnosis of a new extragonadal pelvic lesion in a patient with a history of endometriosis, which would avoid misdiagnosis and missed diagnosis.

Indexed as

Carcinoma, EndometrioidRectal NeoplasmsVaginal NeoplasmsDiagnosis, DifferentialEndometriosisFemaleHumansdeep infiltrating endometriosisendometrioid adenocarcinomaendometriosisrectovaginal septum

Identifiers

PMID37587081
PMCPMC10930444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.